Although molecular methods such as real-time PCR of tumor-specific mRNA expressed by carcinoma, sarcoma or melanoma tumor cells etc., recently called “real time liquid biopsy”, have a higher sensitivity compared to flow cytometry, flow cytometry is still valid for the quantification and characterization of circulating cancer cells